Search Within

Breast Medicine Service

Formats
  1. Journal Article (2206)
  2. Meeting Abstract (1680)
  3. Review (83)
  4. Book Section (69)
  5. Editorial (44)
  6. Conference Paper (28)
  7. Guidelines (27)
  8. Correspondence (16)
  9. Miscellaneous (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Department of Medicine (4181)
  2. Solid Tumor Oncology Division (4181)
  3. Survivorship Research (2373)
  4. GSK Faculty (1516)
  5. Population Sciences Research Program (1369)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (1144)

More Groups

People
  1. Clifford Hudis (906)
  2. Larry Norton (762)
  3. Mark Robson (684)
  4. Neal Rosen (427)
  5. Andrew Seidman (319)
  6. Kenneth Offit (300)

More People

Years
  1. 2025 (130)
  2. 2024 (195)
  3. 2023 (168)
  4. 2022 (219)
  5. 2021 (236)
  6. 2020 (250)

More Years

Publications
  1. Journal of Clinical Oncology (828)
  2. Cancer Research (481)
  3. Breast Cancer Research and Treatment (170)
  4. Annals of Oncology (159)
  5. Clinical Cancer Research (132)
  6. Cancer (78)

More Publications

Publishers
  1. American Society of Clinical Oncology (880)
  2. American Association for Cancer Research (755)
  3. Springer (332)
  4. Elsevier Inc. (308)
  5. Oxford University Press (282)
  6. Nature Publishing Group (276)

More Publishers

Results (4181)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • LY294002-geldanamycin heterodimers as selective inhibitors of the PI3K and PI3K-related family
    Journal Article

    Chiosis, G.; Rosen, N.; Sepp-Lorenzino, L.
    Bioorganic & Medicinal Chemistry Letters (2001)

    Fulltext@MSK | Save
  • Pharmacologic insights into the future of trastuzumab
    Journal Article

    Leyland-Jones, B.; Arnold, A.; Gelmon, K.; Verma, S.; Ayoub, J. P.; Seidman, A.; Dias, R.; Howell, J.; Rakhit, A.
    Annals of Oncology (2001)

    Fulltext@MSK | Save
  • Biological therapy
    Book Section

    Rosen, N.; Sepp-Lorenzino, L.; Lippman, M. E.
    In Harris, J. R.; Lippman, M. E.; Morrow, M.; Hellman, S. (Eds.) Diseases of the Breast. 2nd ed (2000)

    Fulltext@MSK | Save
  • How should we integrate new drugs in the treatment of metastatic breast cancer?
    Book Section

    Hudis, C.
    In Khayat, D.; Hortobagyi, G. N. (Eds.) Progress in Anti-Cancer Chemotherapy. Volume 4 (2000)

    Fulltext@MSK | Save
  • Breast cancer
    Book Section

    Gilewski, T.; Norton, L.
    In Humes, H. D. (Eds.) Kelley's Textbook of Internal Medicine. 4th ed (2000)

    Fulltext@MSK | Save
  • Hereditary breast cancer
    Book Section

    Robson, M. E.
    In Borgen, P. I.; Hill, A. D. K. (Eds.) Breast Diseases (2000)

    Fulltext@MSK | Save
  • Inhibition of wild-type Ras is not an effective anti-cancer strategy in the treatment of breast cancers
    Meeting Abstract

    Moasser, M. M.; Rosen, N.
    Proceedings of the American Association for Cancer Research Annual Meeting (2000)

    Fulltext@MSK | Save
  • Comparison of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) for Her2/neu in metastatic breast cancer (BC)
    Meeting Abstract

    Kaptain, S.; Seidman, A. D.; Esteva, F. J.; Fornier, M.; Arroyo, C.; Chin, J.; Willey, J.; Reuter, V.; Hudis, C.; Norton, L.; more...
    Laboratory Investigation (2000)

    Fulltext@MSK | Save
  • Her-2/neu immunoreactivity in 142 invasive mammary carcinomas (IMC): A comparative study using four antibodies
    Meeting Abstract

    Dadmanesh, F.; Norton, L.; Hudis, C.; Arroyo, C.; Reuter, V. E.; Tan, L. K.
    Laboratory Investigation (2000)

    Fulltext@MSK | Save
  • The integration of new drugs into treatment regimens for breast cancer
    Meeting Abstract

    Hudis, C.
    European Journal of Cancer (2000)

    Fulltext@MSK | Save